Ignite Creation Date:
2024-05-06 @ 5:40 PM
Last Modification Date:
2024-10-26 @ 2:33 PM
Study NCT ID:
NCT05394792
Status:
COMPLETED
Last Update Posted:
2024-04-09
First Post:
2022-05-25
Brief Title:
An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing Dupilumab
Sponsor:
AbbVie
Organization:
AbbVie
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-05-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-05-25
First Submit QC Date:
May 25 2022
Study First Post Date:
2022-05-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-27
Last Update Post Date:
2024-04-09
Last Update Post Date Type:
ACTUAL